Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/34918


2003 Cardiovascular Market Update: Part 2 - Antithrombotics


Description: Introduction According to IMS Health data, global sales of cardiovascular and antithrombotic drugs, i.e. anti-hypertensives, anti-dyslipidemics, antithrombotics and cardiac therapies, reached $72.6bn in 2002. However, competition within each of the four therapy areas is fierce, with many leading brands facing the threat of generic competition and other key patents due to expire over the next five years. Scope - Provide a reference tool for the cardiovascular market, including a comprehensive overview of the antithrombotics market - Detail sales trends from 2001 to 2002 by therapy area, by antithrombotic class and by top 10 antithrombotic brands - Summarize key events in the antithrombotics market in the first half 2003 and analyze their impact on the future dynamics of the market - Identify the key late stage developmental compounds that have the potential to achieve blockbuster status within the antithrombotics market Report Highlights The antithrombotics market continues to show impressive growth, driven by the rapid uptake of Plavix (clopidogrel), which achieved sales of $2.5 billion in 2002 As well as growth in sales of Plavix, growth in the Lmwh market continues as physicians switch away from UFH to the newer Lmwh brands In the future, the launch of AstraZeneca’s Exanta (ximelagatran) may challenge Plavix in certain indications (e.g. post-acs) but is expected to generate significant revenues in the stroke prevention in atrial fibrillation market Reasons to Purchase - Gain an overview of the dynamics of the antithrombotic market in 2003 - Understand the key events impacting the future dynamics and the leading brands within this market - Recognize the threats facing the leading products and identify key opportunities for R&D


Contents: TABLE OF CONTENTS
INTRODUCTION 4
EXECUTIVE SUMMARY 4
Introduction 4
Scope and coverage of the Brief 4
Key findings about the cardiovascular market 5
OVERVIEW OF THE CARDIOVASCULAR MARKET 9
Key events of 2003 12
Overview of cardiovascular late stage R&D 14
ANTITHROMBOTICS 15
Top 10 antithrombotics 16
Key events summary 18
Antithrombotics sales forecasts 64
APPENDIX 66
Bibliography 66




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/34918

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 02/12/2008 03:54:01
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
2003 Cardiovascular Market Update: Part 2 - Antithrombotics
Web Address:
http://www.researchandmarkets.com/reports/34918
Office Code:
OCIFGLIPVUR

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic €2,033.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 02/12/2008 03:54:01

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World